Must Read! Ahead of the Anthropic IPO: Price and Potential

Anthropic stock (ANT) is offered at US$70 to US$78 per share, with pricing scheduled for November 18 and first trade on November 19, 2026 on Nasdaq. Nobody can say for sure where the price will go after listing. This article collects the price views of named analysts, then adds scenario math so you can see what numbers are really being discussed.
This is the IPO that has everyone asking one thing: in or out? Anthropic's revenue is surging, but its compute spending commitments are about US$900 billion and its valuation is near US$1 trillion. Before you get swept up in the hype, read the preparation, who is saying what about the price, and what could go wrong.
Key Takeaways
- Official range: US$70 to US$78 per Class A share, 825 million shares, ticker ANT on the Nasdaq Global Select Market.
- Schedule from media: pricing November 18, first trade November 19, 2026. As of November 17, neither has happened.
- There is no official price prediction. What exists are views from analysts and commentators, some bullish, some cautious.
- Valuation at the range: about US$0.9 to US$1.02 trillion on shares outstanding, and up to about US$1.4 trillion fully diluted.
- A price of US$100 means 28% to 43% above the range. That is simple math, not a target.
- Growth is slowing: Q3 revenue rose about 47% from Q2, down from about 144% in Q2.
- Where to buy: after the listing, through an OJK-licensed exchange as a 1:1 tokenized stock. An ANT token is not yet available on Mobee as of November 17, 2026.
Ahead of the Anthropic IPO: What Has Happened
| Stage | Date | Status |
|---|---|---|
| Public S-1 filing | October 26, 2026 | Official, from Anthropic |
| Roadshow launch and price range | November 10, 2026 | Official, from Anthropic |
| Pricing | November 18, 2026 | Schedule from media reports |
| First trade on Nasdaq | November 19, 2026 | Schedule from media reports |
| Additional share option (greenshoe) | 30 days after the offering | Official, up to 123,750,000 shares |
According to Anthropic's press release, the registration statement has been filed with the SEC but is not yet effective. The offering can only proceed once the SEC declares it effective. Of the 825,000,000 shares offered, 801,351,354 are sold by Anthropic and 23,648,646 by existing stockholders. Goldman Sachs and Morgan Stanley are named as underwriters.
Beyond the public offering, Decrypt and Let's Data Science report a private placement of about US$26 billion in non-voting Class N shares, at the same price public investors pay, from AMD, Broadcom, Google, Micron, Microsoft, NVIDIA, and TSMC. Directors and affiliates also indicated interest in up to US$303 million. That signals insiders and partners are participating, but it is not a guarantee the price will rise.
Numbers can change during the process. On the night of November 9, a leaked document copy showed about 867 million shares at US$70 to US$80. Anthropic called it inaccurate and then published the official range of US$70 to US$78. Rely on official documents, not leaks. The basics of the process are in what is an IPO, and a status summary is in the Anthropic IPO market report.
Anthropic Stock Price Prediction: Who Is Saying What?
None of the sources we read give an official price target for ANT. What exists are views from several figures, quoted via Stocktwits (November 11, 2026):
- Patrick Moorhead (Moor Insights & Strategy) said, "Maybe, just maybe, they are pricing it to go crazy on IPO day." He cited a fully diluted valuation of about US$1.2 to US$1.3 trillion and questioned whether annualized revenue of about US$81 billion can support about US$900.9 billion in spending over a decade.
- Jim Cramer (CNBC) is bullish: revenue growth supports a valuation above US$1 trillion, even though quarterly growth fell from about 144% (Q2) to about 47% (Q3).
- Mohamed El-Erian highlighted nine-month revenue of US$33.2 billion (up about 1,200%) and an annualized run rate of about US$81 billion at the end of October.
- Dan Ives (Yorkville Ives Partners) is cautious: the valuation must be "digestible," and the market ultimately decides the value. He also flagged risks from a tech selloff and the US midterm elections. This is not a price target.
Retail sentiment on Stocktwits was reported to flip from "bearish" to "extremely bullish" within a short time. That is a hype indicator, not a fair-value indicator. It is also worth knowing that some large investors earlier thought the initial valuation target was too high: from about US$2 trillion in September, to about US$1.5 trillion, then talk of about US$1.1 to US$1.3 trillion.
Scenario Math: What Valuation Does Each Price Imply?
The table below is our illustrative math, not a prediction. Valuation is calculated from about 13.09 billion shares outstanding after the IPO (a Decrypt figure). On a fully diluted basis, the valuation at each price would be higher.
| Price per share | Valuation (shares outstanding) | Change from US$78 | Change from US$70 |
|---|---|---|---|
| US$60 | about US$785 billion | down about 23% | down about 14% |
| US$70 (bottom of range) | about US$916 billion | down about 10% | 0% |
| US$78 (top of range) | about US$1.02 trillion | 0% | up about 11% |
| US$90 | about US$1.18 trillion | up about 15% | up about 29% |
| US$100 | about US$1.31 trillion | up about 28% | up about 43% |
| US$120 | about US$1.57 trillion | up about 54% | up about 71% |
How to read it: if you buy at US$100 on the open, you are already paying a valuation of about US$1.3 trillion on shares outstanding. For comparison, a valuation of about US$0.9 to US$1.4 trillion divided by the US$81 billion run rate is about 11 to 17 times annual revenue (our calculation). This is not fair value, just a way to see how expensive the discussed prices are.
A day-one illustration using the SpaceX pattern: Renaissance Capital noted that SpaceX priced at US$135, opened near US$150 (up about 11%), and closed near US$161 (up about 19%). If a similar pattern played out for ANT, the closing price would be roughly US$83 to US$93 from a US$70 to US$78 range. That is one case, not a pattern that is sure to repeat. Large IPOs can also open flat or fall.
Anthropic's Potential: Bull and Bear Arguments
Bull arguments (from the sources above):
- Revenue for the first nine months of 2026 was about US$33.2 billion, versus about US$2.5 billion a year earlier, with a run rate of about US$81 billion at the end of October.
- Operating loss shrank to about US$1.26 billion for the first nine months of 2026 (Decrypt), from about US$5.2 billion in the same period last year (Yahoo Finance).
- The private placement buyers are companies that understand AI compute demand.
Bear arguments:
- Quarter-over-quarter growth slowed from about 144% to about 47%.
- Compute spending commitments are about US$900 billion. Beinsure writes that about US$451.6 billion falls due before the end of 2030, and about US$70 billion within 12 months.
- According to Beinsure, Q3 posted an operating loss of about US$567 million, while Q2 had an operating profit of about US$974 million helped by a compute credit.
- The valuation is already near US$1 trillion, leaving little room for error.
- A narrow customer base, a risk the company itself lists in material quoted by Yahoo Finance.
A net loss of about US$104 billion for nine months looks frightening, but Decrypt says about US$94.3 billion of it is a non-cash charge on convertible debt and similar instruments. Do not read it as cash leaving the company.
Company Control: Why Class A Holders Have Limited Say
Anthropic is a public benefit corporation. The Long-Term Benefit Trust elects a majority of the board, and a single Class F share held by an entity owned by the seven co-founders carries 50.1% of the vote on most matters. Class A shares, sold to the public, carry one vote each. So buying ANT gives you a share of the company's value, not control.
Checklist Before You Buy
- Wait for the final price. Read the final prospectus at pricing, not the old range or leaks.
- Know what you are buying. The real ANT share, a token that follows its price, and a "pre-IPO" product are not the same thing.
- Work out the valuation you are paying. Use the table above to see what valuation each price implies.
- Prepare for the downside. Decide in advance how much loss you can tolerate.
- Be careful with orders in the first minutes. Prices on the first trading day can swing wildly and bid-ask spreads can be wide. Consider limit orders rather than market orders.
- Check fees, exchange rates, and taxes on the platform you use.
- Do not put in money you cannot afford to lose. Learn about crypto trading risk management.
How to Take Part from Indonesia: ANT Stock, Tokens, and "Pre-IPO" Products
According to CNBC via Decrypt, about 20% of the shares are allocated to retail investors. Renaissance Capital cites Bloomberg at 15% to 20% and names Schwab, Fidelity, Robinhood, SoFi, and E*TRADE as distributors. All are US brokers, so availability for investors in Indonesia depends on the platform you use, and an allocation is not guaranteed.
| ANT stock (Class A) | Tokenized stock | "Pre-IPO" product | |
|---|---|---|---|
| What it is | An official share on Nasdaq | A token whose price follows the real share | A product claiming exposure before the listing |
| Voting rights | One vote per Class A share | No shareholder voting rights | Not always clear |
| Available when | After the listing | Once the token issuer makes it available | Before the listing |
| Main risk | Volatility and valuation | Issuer risk, custody, and price gaps | Unclear who holds the shares, high fees, transfer terms |
Before the listing, no ANT shares can be bought on an exchange by the public. If a product offers Anthropic exposure today, ask five questions: who issues it, who holds the underlying shares, whether the company permits that transfer, what the total cost is, and what happens if the IPO is delayed. Unclear answers are a warning sign. More detail is in US tokenized stocks vs regular stocks and how tokenized stocks work.
Where Can You Buy Anthropic Stock?
The short answer: after the listing, you can get exposure to Anthropic stock through a crypto exchange that is licensed and supervised by OJK, in the form of a tokenized stock whose value moves 1:1 with the price of the real share. Choose a legal route, because "pre-IPO" products circulating before the listing do not necessarily give any claim on shares.
Mobee is an exchange licensed and supervised by OJK (trading is facilitated by PT CTXG Indonesia Berkarya, a Digital Financial Asset Trader) and offers tokenized US stocks issued by Ondo. Note that a token is not the share itself, so it carries no voting rights or other shareholder rights. As of November 17, 2026, an Anthropic (ANT) token pair is not yet available on Mobee. Watch Mobee's official announcements for the listing schedule, and do not trust availability claims from other parties. Learn the basics in asset tokenization. To compare with other AI-themed companies, read CoreWeave stock and Nvidia stock performance.
Frequently Asked Questions
What is the Anthropic stock price prediction after the IPO?
There is no official prediction or price target. Analysts and commentators such as Moorhead and Cramer lean bullish, while Ives stresses that the valuation must be digestible. The scenario table in this article is illustrative math, not a prediction.
What is the Anthropic IPO price range?
The official range from Anthropic is US$70 to US$78 per Class A share. The final price is set at pricing and can land inside or outside the range.
When will Anthropic stock start trading?
According to media reports, the price is set on November 18 and trading begins on November 19, 2026 on Nasdaq under the ticker ANT. As of November 17, neither has happened, and the schedule can slip.
Will Anthropic stock rise on day one?
There is no certainty. SpaceX rose about 19% on its first day, but that is one example. Large IPOs can rise, stay flat, or fall.
What are Anthropic stock's biggest potential and risk?
The potential is in very fast revenue growth, with a run rate of about US$81 billion. The risks are slowing growth, about US$900 billion in compute commitments, a valuation near US$1 trillion, and control concentrated in the founders.
Can I buy Anthropic stock from Indonesia?
After the listing, ANT shares can be bought through a securities firm or platform that provides US market access. Retail IPO allocations are distributed through US brokers, so availability differs by platform. Before the listing, be careful with products claiming to sell pre-IPO exposure.
Where can I buy Anthropic stock?
After the listing, you can get exposure through an OJK-licensed crypto exchange as a tokenized stock whose value moves 1:1 with the real share's price. A token is not the share itself. As of November 17, 2026, an Anthropic token pair is not yet available on Mobee; watch Mobee's official announcements.
Conclusion
The Anthropic IPO is attractive because revenue is growing so fast, but the price is already near US$1 trillion, quarter-over-quarter growth is slowing, and compute commitments are very large. The price predictions circulating are people's opinions, not facts, and the scenario table above is only a calculation aid.
Before buying, wait for the final price, understand what you are buying, work out the valuation you are paying, and decide the loss you can tolerate. Do not buy just because everyone else is.
Disclaimer
This article is for information and education only and is not investment, legal, or tax advice, nor a recommendation to buy or sell any asset, nor a reliable price prediction. Analyst views are third-party opinions and the scenario table is illustrative math. IPO shares, tokenized stocks, and crypto assets carry high risk and can fall in value. Data comes from Anthropic's press releases and media reporting as of November 17, 2026; schedules and figures may change. Do your own research and consider your financial situation before making any decision.
Sources: Anthropic, roadshow launch (November 10, 2026); Renaissance Capital (November 10, 2026); Decrypt via Yahoo Finance (November 10, 2026); Stocktwits (November 11, 2026); Let's Data Science (November 10, 2026); Beinsure (November 14, 2026); Yahoo Finance (November 13, 2026).



